Ignite Creation Date:
2024-05-05 @ 5:20 PM
Last Modification Date:
2024-10-26 @ 9:30 AM
Study NCT ID:
NCT00431340
Status:
TERMINATED
Last Update Posted:
2015-07-08
First Post:
2007-02-02
Brief Title:
A Phase II Study of Belinostat in Combination With Bortezomib in Patients With Relapsed Refractory Multiple Myeloma
Sponsor:
Valerio Therapeutics
Organization:
Valerio Therapeutics
Organization Data
Organization:
Valerio Therapeutics
Class:
INDUSTRY
Study ID:
PXD101-CLN-16
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Valerio Therapeutics
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None